ghk cu blood pressure NL-GHK-Cu in the prevention of heart and vessel diseases – Synthagen PL Regenerative and Protective Actions of

The "minimal initial benefit" group (approximately 5-10% of users) reported limited improvements during treatment making discontinuation effects irrelevant, typically explained by inadequate product quality with degraded or low-concentration GHK-Cu, inappropriate application technique reducing absorption, unrealistic expectations exceeding what any topical can achieve, severe underlying pathology requiring medical intervention beyond cosmetic peptides, or individual non-responsiveness to copper peptide treatment for genetic or physiological reasons

Staffa P, Cambi J, Mezzedimi C, Passali D, Bellussi L

Muscle Nerve 56 , E59E64 (2017)

Both compounds are subcutaneous only - no oral or sublingual options

GHK-Cu has been shown in research settings to modulate gene expression related to collagen synthesis, inflammation regulation, and tissue remodeling, making it a focal point in studies involving dermal and connective tissue models